MoneyWorks4Me

A decrease in the sales to Rs. 1369.50 millions was observed for the quarter ended September 2022. The sales stood at Rs. 1604.00 millions during the similar quarter previous year.The Net proft of the company remain more or less same to Rs. 575.10  millions from Rs. 651.60 millions ,decline by -11.74%.The Operating Profit of the company witnessed a decrease to 798.70 millions from 898.20 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 1369.50 1604.00 -14.62 2533.40 2879.00 -12.00 5280.60 4826.80 9.40
Other Income 224.50 184.20 21.88 574.20 377.50 52.11 565.50 186.20 203.71
PBIDT 798.70 898.20 -11.08 1609.50 1654.60 -2.73 2761.70 2325.50 18.76
Interest 0.40 0.20 100.00 0.50 0.50 0.00 0.90 1.70 -47.06
PBDT 798.30 898.00 -11.10 1609.00 1654.10 -2.73 2760.80 2323.80 18.81
Depreciation 65.10 63.10 3.17 128.80 125.10 2.96 257.70 224.40 14.84
PBT 733.20 834.90 -12.18 1480.20 1529.00 -3.19 2503.10 2099.40 19.23
TAX 158.10 183.30 -13.75 272.70 331.90 -17.84 624.40 537.10 16.25
Deferred Tax -17.10 2.80 -710.71 -45.10 5.10 -984.31 8.20 -11.70 -170.09
PAT 575.10 651.60 -11.74 1207.50 1197.10 0.87 1878.70 1562.30 20.25
Equity 151.60 151.30 0.20 151.60 151.30 0.20 151.60 151.30 0.20
PBIDTM(%) 58.32 56.00 4.15 63.53 57.47 10.54 52.30 48.18 8.55
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..